Anaplastic Plasmacytoma - 139 Studies Found
Active, not recruiting |
: Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant :
|
Completed |
: UARK 2005-05, Coagulation-Related Effects of Velcade Treatment in Patients With Relapsed or Refractory Multiple Myeloma : MULTIPLE MYELOMA : 2007-12-07 : Drug: Velcade Except for the two PCR-based genotyping assa |
Completed |
: Comparable Investigation of One Fraction Radiotherapy and Multifraction Radiotherapy in Patients With Multiple Myeloma. : Multiple Myeloma and Malignant Plasma Cell Neoplasms : 2013-12-19 : Radiation: External Beam radiotherapy External Beam radiotherapy |
Active, not recruiting |
: Busulfan, Cyclophosphamide, and Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma : Multiple Myeloma and Plasma Cell Neoplasm : 2009-07-17 :
|
Completed |
: Treated T Cells Followed by a Stem Cell Transplant in Treating Patients With Multiple Myeloma : Multiple Myeloma and Plasma Cell Neoplasm : 2009-07-11 :
|
Completed |
: Studying Blood Samples From Patients With Multiple Myeloma Who Were Treated With Thalidomide or Lenalidomide : Multiple Myeloma and Plasma Cell Neoplasm : 2009-05-09 :
|
Completed |
: Study of DNA Samples From Patients With Multiple Myeloma : Multiple Myeloma and Plasma Cell Neoplasm : 2009-05-09 : Genetic: polymorphism analysis |
Active, not recruiting |
: Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction :
: 2008-11-13 :
|
Active, not recruiting |
: Vorinostat and Lenalidomide After Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma :
: 2008-08-06 :
|
Completed |
: Samarium Sm 153 Lexidronam Pentasodium and High-Dose Melphalan in Treating Patients With Multiple Myeloma Undergoing Stem Cell Transplant : Multiple Myeloma and Plasma Cell Neoplasm : 2008-01-15 :
|